11:50 AM EDT, 04/29/2025 (MT Newswires) -- Quanterix ( QTRX ) and Akoya Biosciences ( AKYA ) said Tuesday they updated the terms of their previously announced merger.

Under the revised agreement, Quanterix ( QTRX ) will issue about 7.76 million shares and pay $20 million in cash to Akoya shareholders, the companies said.

Each Akoya share will now be exchanged for $0.38 in cash and 0.1461 shares of Quanterix ( QTRX ) common stock, it added.

The updated terms reduce the number of Quanterix ( QTRX ) shares to be issued by more than 9 million compared to the original agreement, according to the companies.

Quanterix ( QTRX ) shareholders will own about 84% of the combined company. Akoya shareholders will own about 16%.

Both Quanterix's ( QTRX ) and Akoya's boards have approved the amended merger terms and Akoya shareholders holding more than half of the company's stock have agreed to support the revised deal, the joint statement added.

Due to the amendment, Quanterix ( QTRX ) has canceled its planned special meeting of shareholders, according to the joint statement.

The merger is expected to close in Q2, pending Akoya shareholder approval, the companies added.

Shares of Quanterix ( QTRX ) were up about 3.6%, while Akoya's stock was down 5.3% in recent trading.

Price: 6.05, Change: +0.27, Percent Change: +4.67